Semaglutide activates these same pathways, creating a coordinated effect across appetite regulation, blood sugar stability, and metabolic rate
Safety Considerations and Monitoring Requirements Before starting semaglutide or any GLP-1 medication, inform your doctor about every antidepressant and psychiatric medication you use, including dosage and duration of treatment
By activating both GIP and GLP-1 receptors, tirzepatide enhances insulin secretion in a glucose-dependent manner, suppresses glucagon release, slows gastric emptying, and reduces appetitecollectively improving glycaemic control and promoting weight loss
Follow the storage instructions provided with your product
Think of it like removing a bandage: fast is better
Yamada, Y., Katagiri, H., Hamamoto, Y., Deenadayalan, S., Navarria, A., & Irie, S